Clinical benefits of adjuvant chemotherapy with carboplatin and gemcitabine in patients with non-small cell lung cancer: a single-center retrospective study

Clinical benefits of adjuvant chemotherapy with carboplatin and gemcitabine in patients with non-small cell lung cancer: a single-center retrospective study

Abstract Purpose In cases of non-small cell lung cancer (NSCLC), surgery remains the best option for cure, but surgery is of benefit only when the disease is localized. Although adjuvant chemotherapy reportedly has a significant beneficial effect on survival, the benefit of a carboplatin (CBDCA) reg...

Full description

Bibliographic Details
Main Authors: Shinogu Takashima, Kazuhiro Imai, Maiko Atari, Tsubasa Matsuo, Katsutoshi Nakayama, Yusuke Sato, Satoru Motoyama, Hiroyuki Shibata, Kyoko Nomura, Yoshihiro Minamiya
Format: Article
Language:English
Published: BMC 2020-10-01
Series:World Journal of Surgical Oncology
Subjects:
Carboplatin
Gemcitabine
Adjuvant chemotherapy
Lung cancer
Online Access:http://link.springer.com/article/10.1186/s12957-020-02041-0

Internet

http://link.springer.com/article/10.1186/s12957-020-02041-0

Similar Items